Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
97.014,61
0,54%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Outlook Therapeutics Inc (OTLK) Outlook Therapeutics Inc (OTLK) Notizie

Outlook Therapeutics Inc

OTLK
1,75
0,02 (1,16%)
08 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/2/202522:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202515:05GLOBEOutlook Therapeutics® Participates in Virtual Investor “What..
31/1/202522:46EDGAR2Form PRE 14A - Other preliminary proxy statements
31/1/202522:39EDGAR2Form 8-K - Current report
31/1/202514:05GLOBEOutlook Therapeutics® Appoints Faisal G. Sukhtian as..
27/1/202523:04EDGAR2Form D - Notice of Exempt Offering of Securities
23/1/202523:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
23/1/202515:05GLOBEOutlook Therapeutics® Announces Presentation of Efficacy and..
22/1/202522:17EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
22/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202515:05GLOBEOutlook Therapeutics® to Present at LIVE! with Webull..
16/1/202523:16EDGAR2Form 8-K - Current report
16/1/202512:00GLOBEOutlook Therapeutics® Announces Complete Twelve Week..
08/1/202515:15GLOBEOutlook Therapeutics® Participates in Virtual Investor “What..
27/12/202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/12/202414:14EDGAR2Form 8-K - Current report
27/12/202414:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
16/12/202422:11EDGAR2Form 8-K - Current report
13/12/202422:30GLOBEOutlook Therapeutics® Streamlines Operations
04/12/202414:05GLOBEOutlook Therapeutics® Announces NICE Recommendation of..
04/12/202413:27EDGAR2Form 8-K - Current report
03/12/202422:30GLOBEOutlook Therapeutics® Announces Executive Leadership..
27/11/202418:26EDGAR2Form 8-K - Current report
27/11/202412:50GLOBEOutlook Therapeutics® Announces Preliminary Topline Results..
06/11/202414:05GLOBEOutlook Therapeutics® to Present at the Guggenheim..
17/10/202415:00GLOBEOutlook Therapeutics® Participates in a Virtual Investor CEO..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202414:05GLOBEOutlook Therapeutics® to Participate in the Virtual Investor..
13/9/202415:05GLOBEOutlook Therapeutics® Participates in the 2nd Annual Chardan..
04/9/202414:35GLOBEOutlook Therapeutics® Announces Completion of Enrollment in..
03/9/202414:45GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 26th..
14/8/202422:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202413:48EDGAR2Form 8-K - Current report
14/8/202413:05GLOBEOutlook Therapeutics® Reports Financial Results for Third..
12/8/202415:05GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 4th..
07/8/202414:35GLOBEOutlook Therapeutics® to Report Financial Results for Third..
30/7/202415:10GLOBEOutlook Therapeutics® to Present at the BTIG Virtual..
08/7/202414:41EDGAR2Form 8-K - Current report
08/7/202414:35GLOBEOutlook Therapeutics® Announces UK MHRA Marketing..
14/6/202422:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/6/202415:05GLOBEOutlook Therapeutics® to Present at the Virtual Investor..
28/5/202414:05GLOBEOutlook Therapeutics® Receives European Commission Marketing..
15/5/202423:19EDGAR2Form 8-K - Current report
15/5/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202423:00GLOBEOutlook Therapeutics® Reports Financial Results for Second..
13/5/202422:05EDGAR2Form 8-K - Current report
Apertura: 1,74 Min: 1,66 Max: 1,78
Chiusura: 1,73

La tua Cronologia

NASDAQ
OTLK
Outlook Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci